Nordic walking may benefit breast cancer patients
(Reuters Health) – Nordic walking, an aerobic activity performed with walking poles similar to ski poles, may benefit patients with breast cancer, according to a review of existing research. The…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (Reuters) – Roche Holding AG has priced its personalized…
FDA approves Celgene’s bone marrow cancer treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved…
Virtual reality experiences can help ease severe pain
(Reuters Health) – Playing virtual reality games or relaxing in a virtual nature setting might help ease chronic pain, particularly when symptoms are severe, a new experiment suggests. The 120…
Poorer kids may have less shade in their schoolyards
(Reuters Health) – Elementary schools with the greatest proportions of poor children may have the least amount of shade in their schoolyards where kids spend their recess, a new U.S.…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said,…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said,…
Medicare to cover expensive cancer cell therapies
FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters) – The U.S. Centers for Medicare and Medicaid Services (CMS)…
Hairdressers are willing to help customers detect skin cancers
(Reuters Health) – Most hair stylists at salons and barber shops may be interested in getting trained to detect skin cancers on the scalp, face and neck, researchers say. Since…
Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in Europe to tackle tumours with a specific genetic mutation regardless…